on-visual effects of light (NiviL): optimized light to improve health of elderly people in senior residences
Not Applicable
Completed
- Conditions
- kognitiver Status in elderly people
- Registration Number
- DRKS00012470
- Lead Sponsor
- niversitätsklinikum Tübingen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 198
Inclusion Criteria
Nursing home residents in Markwasen in Reutlingen and Herzog-Christoph in Bad Urach
- Residents that are not able to give consent (with consent from their legal adviser
- Nursing staff
Exclusion Criteria
- Severe affective disorder (GDS > 9)
- Diseases that can cause damage to the cirkadian effective intrinsic photosensitive ganglion cells (IpRGC) (e.g. glaucoma, Opticusneuropathy)
- Insufficient knowledge of German language
- advanced state of cataract
- Palliativesituation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increased Activity (Questionnaire/Surveillance questionnaire ADL, GDS, Actimetry) at<br>Week 0 (Baseline), Week 3, week 6, week 12
- Secondary Outcome Measures
Name Time Method Improved mental state (questionnaire SF12), Change of circadiane rhythm (Actigraphy, Melatonin-measurement), Mood (Questionnaires GDS, OERS) and Cognition (Audio reaction time test AuReTim, questionnaire DemTect) at Week 0 (Baseline) week 3, week 6 and week 12
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie light therapy's impact on cognitive status in elderly populations?
How does optimized light intervention compare to standard-of-care treatments for cognitive decline in senior residences?
Are there specific biomarkers that predict response to non-visual light therapy in geriatric patients?
What adverse events are associated with non-visual light exposure in elderly individuals with cognitive impairments?
What combination therapies or light wavelengths show promise for enhancing cognitive health in aging populations?